Literature DB >> 21717777

[Effect of moxibustion on ultrastructure of synovial cells in rheumatoid arthritis rats].

Lei Luo1, Ling Hu, Lu He, Zhao-liang Tang, Xiao-ge Song, Lars Dirckinck-Holmfeld, Rong-lin Cai.   

Abstract

OBJECTIVE: To observe the influence of moxibustion of "Shenshu"(BL 23) and "Zusanli" (ST 36) on the microstructure of synovial cells in the knee-joint in rheumatoidarthritis (RA) rats so as to study its underlying mechanism in anti-inflammatory immune effect.
METHODS: A total of 120 Wistar rats were randomized into normal control, model, acupuncture, moxibustion, CO2-laser and medication groups (n = 20/group). RA model was duplicated by raising the rats in a windy (electro-fan blowing), cold [(6 +/- 2) degrees] and wet (80%-90%) environment for 12 h/d and 20 days, followed by injecting Freund's complete adjuvant (0.15 mL) into the rat's ankle. Moxibustion or acupuncture or CO2 laser (10.6 microm) irradiation was applied to "Shenshu" (BL 23) and "Zusanli" (ST 36) for 20 min, once daily for 15 days. Intragastric perfusion of Leigongteng (Tripterygium Wilfordii Hook.f.) was given to medication group, 8 mg/kg, once daily for 15 days. The thoracic gland index [weight of the thoracic gland (mg)/ body weight (g) x 100%] and spleen index [weight of the spleen (mg)/body weight (g) x 100%] were calculated after killing the rats under anesthesia. The ultrastructure of synovial cells of the knee-joint was observed by using transmission electron microscopy.
RESULTS: In comparison with the normal control group, the thoracic gland index in the model group was decreased significantly (P < 0.01), while the spleen index of the model group increased considerably (P < 0.05). In comparison with the model group, the thoracic gland indexes in the acupuncture, moxibustion, CO-laser and medication groups were increased significantly (P < 0.05, P < 0.01), whereas the spleen indexes in the four groups decreased evidently (P < 0.05). No significant differences were found among the acupuncture, moxibustion, CO2-laser and medication groups in up-regulating the thoracic gland index and down-regulating the spleen index (P > 0.05). After modeling, the synoviocytes of the knee-joint were impaired remarkably, exhibiting incomplete cellular membrane, some prolapsed organelles, marginalized stained granules in the cellular nucleus, vague nuclear membrane, enlarged rough endoplasmic reticulum, reduction in the number of mitochondria with vacuolization degeneration and multiple lysosomes. But, the pathological changes of the ultrastructure of most synoviocytes in the acupuncture, moxibustion, CO2-laser and medication groups were relatively milder.
CONCLUSION: Moxibustion can protect the immune organs (thoracic gland and spleen) from injury and improve pathological changes of the ultrastructure of local synoviocytes in RA rats.

Entities:  

Mesh:

Year:  2011        PMID: 21717777

Source DB:  PubMed          Journal:  Zhen Ci Yan Jiu        ISSN: 1000-0607


  4 in total

1.  Protective effect of taraxasterol against rheumatoid arthritis by the modulation of inflammatory responses in mice.

Authors:  Shu-Hua Jiang; Li-Feng Ping; Feng-Yan Sun; Xiao-Lei Wang; Zhi-Juan Sun
Journal:  Exp Ther Med       Date:  2016-11-02       Impact factor: 2.447

2.  Paeoniflorin ameliorates rheumatoid arthritis in rat models through oxidative stress, inflammation and cyclooxygenase 2.

Authors:  Zhilin Jia; Jiao He
Journal:  Exp Ther Med       Date:  2015-12-02       Impact factor: 2.447

3.  An analysis of Treg/Th17 cells imbalance associated microRNA networks regulated by moxibustion therapy on Zusanli (ST36) and Shenshu (BL23) in mice with collagen induced arthritis.

Authors:  Chuang Zhao; Xiaoyan Li; Yan Yang; Zunyuan Li; Miao Li; Qian Tan; Wei Liang; Zhidan Liu
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

4.  Retinoic Acid-Platinum (II) Complex [RT-Pt(II)] Protects Against Rheumatoid Arthritis in Mice via MEK/Nuclear Factor kappa B (NF-κB) Pathway Downregulation.

Authors:  Ziqiang Cui; Yaping Lin; Yuhong Liu; Ling Cao; Li Cui
Journal:  Med Sci Monit       Date:  2020-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.